Successful treatment of paraneoplastic pemphigus and bronchiolitis obliterans associated with follicular lymphoma with obinutuzumab and bendamustine

被引:4
作者
Kuriyama, Kodai [1 ]
Kitamura, Yoshimi [2 ,3 ]
Tsuji, Taisuke [4 ]
Nishikawa, Rina [1 ]
Nagata, Hiroaki [1 ]
Ohshiro, Muneo [1 ]
Sugitani, Mio [1 ]
Hirakawa, Yoshiko [1 ]
Matsumoto, Yosuke [1 ]
Iwai, Toshiki [1 ]
Uchiyama, Hitoji [1 ]
机构
[1] Japanese Red Cross Kyoto Daiichi Hosp, Dept Hematol, Kyoto, Japan
[2] Japanese Red Cross Kyoto Daiichi Hosp, Dept Dermatol, Kyoto, Japan
[3] Kyoto City Hosp, Dept Dermatol, Kyoto, Japan
[4] Japanese Red Cross Kyoto Daiichi Hosp, Dept Resp Med, Kyoto, Japan
关键词
Obinutuzumab; Bendamustine; Follicular lymphoma; Paraneoplastic pemphigus; Bronchiolitis obliterans; MANTLE-CELL LYMPHOMAS; OPEN-LABEL; 1ST-LINE TREATMENT; PLUS RITUXIMAB; MULTICENTER; PREDNISONE; PHASE-3; CHOP; CYCLOPHOSPHAMIDE; CHEMOTHERAPY;
D O I
10.1016/j.currproblcancer.2021.100813
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We herein report the rare case of a 72-year-old female who presented with paraneoplastic pemphigus (PNP) and bronchiolitis obliterans (BO) associated with follicular lymphoma (FL), who was successfully treated with obinutuzumab (GA101; G) and bendamustine (B). The patient had severe erosive stomatitis and bilateral conjunctival hyperemia that persisted for more than 6 months. A huge mass was found in the abdominal cavity, and a biopsy revealed grade 1 FL (stage IV). Based on a lip biopsy result, the pa-tient was diagnosed with PNP associated FL. The patient received bendamustine and obinutuzumab (BG) chemotherapy and FL and PNP responded very well, but BO was additionally associated during the course of BG. BO progressed without exacerbation as BG therapy progressed to a 2 year maintenance therapy with G, and combination of azithromycin, inhaled bronchodilator therapy, and corticosteroid. She was followed up at the outpatient department with no pulmonary function decline or FL and PNP recurrence. Our case suggests that BG could be a promising treatment option for PNP and BO.(c) 2021 Elsevier Inc. All rights reserved.
引用
收藏
页数:6
相关论文
共 25 条
  • [1] PARANEOPLASTIC PEMPHIGUS - AN AUTOIMMUNE MUCOCUTANEOUS DISEASE ASSOCIATED WITH NEOPLASIA
    ANHALT, GJ
    KIM, S
    STANLEY, JR
    KORMAN, NJ
    JABS, DA
    KORY, M
    IZUMI, H
    RATRIE, H
    MUTASIM, D
    ARISSABDO, L
    LABIB, RS
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (25) : 1729 - 1735
  • [2] The optimal oral biopsy site for diagnosis of mucous membrane pemphigoid and pemphigus vulgaris
    Carey, B.
    Joshi, S.
    Abdelghani, A.
    Mee, J.
    Andiappan, M.
    Setterfield, J.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2020, 182 (03) : 747 - 753
  • [3] Chan WC, 1997, BLOOD, V89, P3909
  • [4] García-Río F, 1999, NEW ENGL J MED, V341, P848
  • [5] Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone:: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group
    Hiddemann, W
    Kneba, M
    Dreyling, M
    Schmitz, N
    Lengfelder, E
    Schmits, R
    Reiser, M
    Metzner, B
    Harder, H
    Hegewisch-Becker, S
    Fischer, T
    Kropff, M
    Reis, HE
    Freund, M
    Wörmann, B
    Fuchs, R
    Planker, M
    Schimke, J
    Eimermacher, H
    Trümper, L
    Aldaoud, A
    Parwaresch, R
    Unterhalt, M
    [J]. BLOOD, 2005, 106 (12) : 3725 - 3732
  • [6] Paraneoplastic pemphigus occurring after bendamustine and rituximab therapy for relapsed follicular lymphoma
    Higo, Takashi
    Miyagaki, Tomomitsu
    Nakamura, Fumihiko
    Shinohara, Akihito
    Asano, Hiroki
    Abe, Hiroyuki
    Senda, Naoyuki
    Yoshizaki, Ayumi
    Fukayama, Masashi
    Kurokawa, Mineo
    [J]. ANNALS OF HEMATOLOGY, 2015, 94 (04) : 683 - 685
  • [7] Rituximab Monotherapy and Rituximab-Containing Chemotherapy Were Effective for Paraneoplastic Pemphigus Accompanying Follicular Lymphoma, but not for Subsequent Bronchiolitis Obliterans
    Hirano, Taichi
    Higuchi, Yusuke
    Yuki, Hiromichi
    Hirata, Shinya
    Nosaka, Kisato
    Ishii, Norito
    Hashimoto, Takashi
    Mitsuya, Hiroaki
    Okuno, Yutaka
    [J]. JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2015, 55 (02) : 83 - 88
  • [8] Peri-anal Paraneoplastic Pemphigus Heralding the Relapse of Follicular Lymphoma and Its Successful Management by Rituximab: A Short Correspondence
    Jain, Ankur
    Prakash, Gaurav
    Nampoothiri, Ram V.
    De, Dipankar
    Bal, Amanjit
    Khadwal, Alka
    Lad, Deepesh
    Malhotra, Pankaj
    Varma, Subhash
    [J]. INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2016, 32 (04) : 519 - 521
  • [9] First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial
    Joly, Pascal
    Maho-Vaillant, Maud
    Prost-Squarcioni, Catherine
    Hebert, Vivien
    Houivet, Estelle
    Calbo, Sebastien
    Caillot, Frederique
    Golinski, Marie Laure
    Labeille, Bruno
    Picard-Dahan, Catherine
    Paul, Carle
    Richard, Marie-Aleth
    Bouaziz, Jean David
    Duvert-Lehembre, Sophie
    Bernard, Philippe
    Caux, Frederic
    Alexandre, Marina
    Ingen-Housz-Oro, Saskia
    Vabres, Pierre
    Delaporte, Emmanuel
    Quereux, Gaelle
    Dupuy, Alain
    Debarbieux, Sebastien
    Avenel-Audran, Martine
    D'Incan, Michel
    Bedane, Christophe
    Beneton, Nathalie
    Jullien, Denis
    Dupin, Nicolas
    Misery, Laurent
    Machet, Laurent
    Beylot-Barry, Marie
    Dereure, Olivier
    Sassolas, Bruno
    Vermeulin, Thomas
    Benichou, Jacques
    Musette, Philippe
    [J]. LANCET, 2017, 389 (10083) : 2031 - 2040
  • [10] Successful treatment with bendamustine and rituximab for paraneoplastic pemphigus
    Kikuchi, Taku
    Mori, Takehiko
    Shimizu, Takayuki
    Koda, Yuya
    Abe, Ryohei
    Kurihara, Yuichi
    Funakoshi, Takeru
    Yamagami, Jun
    Sato, Hidekazu
    Tsunoda, Kazuyuki
    Amagai, Masayuki
    Okamoto, Shinichiro
    [J]. ANNALS OF HEMATOLOGY, 2017, 96 (07) : 1221 - 1222